Vitaly P. Pozharov - Search Results

Year	Number of Results
2006	1
2008	3
2009	2
2010	1
2012	1
2013	1
2023	1
2024	0

1

Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges.

Pozharov VP, Minko T. Pozharov VP, et al. Pharmaceutics. 2023 Jan 5;15(1):194. doi: 10.3390/pharmaceutics15010194. Pharmaceutics. 2023. PMID: 36678823 Free PMC article. Review.

2

Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Ivanova V, Garbuzenko OB, Reuhl KR, Reimer DC, Pozharov VP, Minko T. Ivanova V, et al. Among authors: pozharov vp. Eur J Pharm Biopharm. 2013 Jun;84(2):335-44. doi: 10.1016/j.ejpb.2012.11.023. Epub 2012 Dec 8. Eur J Pharm Biopharm. 2013. PMID: 23228437 Free PMC article.

3

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T. Garbuzenko OB, et al. Among authors: pozharov vp. Pharm Res. 2009 Feb;26(2):382-94. doi: 10.1007/s11095-008-9755-4. Epub 2008 Oct 29. Pharm Res. 2009. PMID: 18958402

4

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T. Taratula O, et al. Among authors: pozharov vp. J Control Release. 2009 Dec 16;140(3):284-93. doi: 10.1016/j.jconrel.2009.06.019. Epub 2009 Jun 28. J Control Release. 2009. PMID: 19567257 Free PMC article.

5

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T. Saad M, et al. Among authors: pozharov vp. J Control Release. 2008 Sep 10;130(2):107-14. doi: 10.1016/j.jconrel.2008.05.024. Epub 2008 Jun 25. J Control Release. 2008. PMID: 18582982 Free PMC article.

6

Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance.

Garbuzenko OB, Saad M, Pozharov VP, Reuhl KR, Mainelis G, Minko T. Garbuzenko OB, et al. Among authors: pozharov vp. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10737-42. doi: 10.1073/pnas.1004604107. Epub 2010 May 24. Proc Natl Acad Sci U S A. 2010. PMID: 20498076 Free PMC article.

7

Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, Soldatenkov VA, Pozharov VP, Minko T. Wang Y, et al. Among authors: pozharov vp. Clin Cancer Res. 2008 Jun 1;14(11):3607-16. doi: 10.1158/1078-0432.CCR-07-2020. Clin Cancer Res. 2008. PMID: 18519795

8

Novel polymeric prodrug with multivalent components for cancer therapy.

Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T. Khandare JJ, et al. Among authors: pozharov vp. J Pharmacol Exp Ther. 2006 Jun;317(3):929-37. doi: 10.1124/jpet.105.098855. Epub 2006 Feb 9. J Pharmacol Exp Ther. 2006. PMID: 16469865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year